Stay updated on Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.

Latest updates to the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNew record revision v3.6.6 was added to the history, and the previous revision v3.6.5 was removed. This updates the study's version history.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedStudy Status and Recruitment Status were updated on 2026-08-14 to Suspended, with a sponsor note that ECR003 activities must halt and no additional subjects may be enrolled. This replaces the prior Active, not recruiting status recorded on 2025-10-20.SummaryDifference0.8%

- Check34 days agoChange DetectedA new revision entry 'Revision: v3.6.5' was added to the record history, signaling an update to the study record. The previous revision 'Revision: v3.6.4' was removed from the visible history.SummaryDifference0.1%

- Check48 days agoChange DetectedThe study record history now includes a new revision entry v3.6.4, replacing the previous revision v3.6.3, reflecting an update to the release notes for the page.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry (v3.6.3) appears in the study history, replacing the previous revision (v3.6.2). This indicates an update to the study record's metadata.SummaryDifference0.1%

- Check76 days agoChange DetectedThe record history shows a newer page revision (v3.6.2) replacing the previous one (v3.6.0), indicating an update to the page's underlying software or layout.SummaryDifference0.1%

Stay in the know with updates to Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.